Marcela M. Cordero Garcia

Array ( [id] => 4477281 [patent_doc_number] => 07906479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Sterile suspensions of slightly soluble basic peptide complexes and pharmaceutical formulations containing them' [patent_app_type] => utility [patent_app_number] => 12/100674 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18680 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 389 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906479.pdf [firstpage_image] =>[orig_patent_app_number] => 12100674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401712 [patent_doc_number] => 08691764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Inhibitors of NF-κB activity' [patent_app_type] => utility [patent_app_number] => 12/593550 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 44 [patent_no_of_words] => 14143 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927334 [patent_doc_number] => 20080166697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'DETERMINATION OF TESTOSTERONE BY MASS SPECTROMETRY' [patent_app_type] => utility [patent_app_number] => 12/053325 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9699 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166697.pdf [firstpage_image] =>[orig_patent_app_number] => 12053325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432024 [patent_doc_number] => 20100143454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Flavivirus NS5A Proteins For the Treatment of HIV' [patent_app_type] => utility [patent_app_number] => 12/532064 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 33379 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143454.pdf [firstpage_image] =>[orig_patent_app_number] => 12532064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4822937 [patent_doc_number] => 20080227688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Inhibition of viral replication' [patent_app_type] => utility [patent_app_number] => 12/075679 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15397 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227688.pdf [firstpage_image] =>[orig_patent_app_number] => 12075679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614626 [patent_doc_number] => 20100099627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'NUCLEAR TARGETING SEQUENCES' [patent_app_type] => utility [patent_app_number] => 12/528465 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23742 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099627.pdf [firstpage_image] =>[orig_patent_app_number] => 12528465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6442182 [patent_doc_number] => 20100104623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'AGENT FOR ENHANCING THE RESISTANCE OF LIPOSOME AGAINST BIOLOGICAL COMPONENT, AND LIPOSOME MODIFIED WITH THE AGENT' [patent_app_type] => utility [patent_app_number] => 12/449817 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6102 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104623.pdf [firstpage_image] =>[orig_patent_app_number] => 12449817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867450 [patent_doc_number] => 20080146509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN' [patent_app_type] => utility [patent_app_number] => 12/036466 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7337 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146509.pdf [firstpage_image] =>[orig_patent_app_number] => 12036466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236197 [patent_doc_number] => 20100267610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Polypeptide comprising a knottin protein moiety' [patent_app_type] => utility [patent_app_number] => 12/527201 [patent_app_country] => US [patent_app_date] => 2008-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10684 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267610.pdf [firstpage_image] =>[orig_patent_app_number] => 12527201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786374 [patent_doc_number] => 20080139703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Method for Preparing Lipid-Spacer-Reactive Functional Group-Peptide' [patent_app_type] => utility [patent_app_number] => 12/029324 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3925 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139703.pdf [firstpage_image] =>[orig_patent_app_number] => 12029324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431927 [patent_doc_number] => 20100143444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES ASSOCIATED WITH EYE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/027728 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 56300 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143444.pdf [firstpage_image] =>[orig_patent_app_number] => 12027728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503492 [patent_doc_number] => 08034762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Treatment of subarachnoid hemorrhage with Apo E analogs' [patent_app_type] => utility [patent_app_number] => 12/023288 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18469 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034762.pdf [firstpage_image] =>[orig_patent_app_number] => 12023288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727984 [patent_doc_number] => 20080207528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'HCV PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/023345 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24325 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207528.pdf [firstpage_image] =>[orig_patent_app_number] => 12023345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813852 [patent_doc_number] => 20080194483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'GLP-1 (9-36) methods and compositions' [patent_app_type] => utility [patent_app_number] => 12/008362 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10736 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194483.pdf [firstpage_image] =>[orig_patent_app_number] => 12008362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222346 [patent_doc_number] => 20100056429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'TREATMENT OF RESPIRATORY CHAIN DISORDERS USING COMPOUNDS HAVING ERYTHROPOIETIN OR THROMBOPOIETIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/522912 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10089 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056429.pdf [firstpage_image] =>[orig_patent_app_number] => 12522912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353723 [patent_doc_number] => 20100086594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'WATER SOLUBLE REACTIVE DERIVATIVES OF CARBOXY POLYSACCHARIDES AND FIBRINOGEN CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/522092 [patent_app_country] => US [patent_app_date] => 2008-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15442 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086594.pdf [firstpage_image] =>[orig_patent_app_number] => 12522092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834525 [patent_doc_number] => 08450281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy' [patent_app_type] => utility [patent_app_number] => 12/522118 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8702 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12522118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285399 [patent_doc_number] => 20090099074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'MODULATING FOOD INTAKE' [patent_app_type] => utility [patent_app_number] => 11/965288 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15273 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099074.pdf [firstpage_image] =>[orig_patent_app_number] => 11965288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231523 [patent_doc_number] => 20100184694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/520803 [patent_app_country] => US [patent_app_date] => 2007-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 18491 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184694.pdf [firstpage_image] =>[orig_patent_app_number] => 12520803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490827 [patent_doc_number] => 20090291898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity' [patent_app_type] => utility [patent_app_number] => 12/004397 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 36656 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291898.pdf [firstpage_image] =>[orig_patent_app_number] => 12004397 [rel_patent_id] =>[rel_patent_doc_number] =>)